Cathepsin S dominates autoantigen processing in human thymic dendritic cells

Journal of Autoimmunity

Volumn 38, Issue 4, 2012, Pages 332-343

  Stoeckle, Christina ^a   Quecke, Paula ^a   Rückrich, Thomas ^b   Burster, Timo ^b   Reich, Michael ^b   Weber, Ekkehard ^c   Kalbacher, Hubert ^b   Driessen, Christoph ^b,d   Melms, Arthur ^a   Tolosa, Eva ^a,e  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Antigen processing; Autoantigen; Cathepsin; Myelin basic protein; Proinsulin; Thymus

Indexed keywords

AUTOANTIGEN; CATHEPSIN S; COMPLEMENTARY DNA; MYELIN BASIC PROTEIN; PROINSULIN; RNA; RNA ISOFORM;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYSOSOME; MYELOID DENDRITIC CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; AUTOANTIGENS; CATHEPSINS; DENDRITIC CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PROINSULIN; THYMUS GLAND;

EID: 84861192687     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.02.003     Document Type: Article

References (62)

1. Gill J., Malin M., Sutherland J., Gray D., Hollander G., Boyd R. Thymic generation and regeneration. Immunol Rev 2003, 195:28-50.
2. Klein L., Hinterberger M., Wirnsberger G., Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 2009, 9(12):833-844.
3. Laufer T.M., DeKoning J., Markowitz J.S., Lo D., Glimcher L.H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 1996, 383(6595):81-85.
4. Anderson G., Owen J.J., Moore N.C., Jenkinson E.J. Thymic epithelial cells provide unique signals for positive selection of CD4+CD8+ thymocytes in vitro. J Exp Med 1994, 179(6):2027-2031.
5. Jenkinson E.J., Anderson G., Owen J.J. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J Exp Med 1992, 176(3):845-853.
6. Gallegos A.M., Bevan M.J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 2004, 200(8):1039-1049.
7. Brocker T., Riedinger M., Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997, 185(3):541-550.
8. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298(5597):1395-1401.
9. Kyewski B., Klein L. A central role for central tolerance. Annu Rev Immunol 2006, 24:571-606.
10. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 2006, 7(10):1092-1100.
11. Millet V., Naquet P., Guinamard R.R. Intercellular MHC transfer between thymic epithelial and dendritic cells. Eur J Immunol 2008, 38(5):1257-1263.
12. Martin-Gayo E., Sierra-Filardi E., Corbi A.L., Toribio M.L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 2010, 115(26):5366-5375.
13. Anderson G., Partington K.M., Jenkinson E.J. Differential effects of peptide diversity and stromal cell type in positive and negative selection in the thymus. J Immunol 1998, 161(12):6599-6603.
14. Munz C. Enhancing immunity through autophagy. Annu Rev Immunol 2009, 27:423-449.
15. Villadangos J.A., Bryant R.A., Deussing J., Driessen C., Lennon-Dumenil A.M., Riese R.J., et al. Proteases involved in MHC class II antigen presentation. Immunol Rev 1999, 172:109-120.
16. Honey K., Nakagawa T., Peters C., Rudensky A. Cathepsin L regulates CD4 + T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J Exp Med 2002, 195(10):1349-1358.
17. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998, 280(5362):450-453.
18. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., et al. Impaired invariant chain degradation and antigen presentation and Diminished collagen-induced arthritis in cathepsin S Null mice. Immunity 1999, 10(2):207-217.
19. Yang H., Kala M., Scott B.G., Goluszko E., Chapman H.A., Christadoss P. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis. J Immunol 2005, 174(3):1729-1737.
20. Watts C., Moss C.X., Mazzeo D., West M.A., Matthews S.P., Li D.N., et al. Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann N Y Acad Sci 2003, 987:9-14.
21. Watts C., Matthews S.P., Mazzeo D., Manoury B., Moss C.X. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunol Rev 2005, 207:218-228.
22. Manoury B., Hewitt E.W., Morrice N., Dando P.M., Barrett A.J., Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 1998, 396(6712):695-699.
23. Manoury B., Mazzeo D., Fugger L., Viner N., Ponsford M., Streeter H., et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat Immunol 2002, 3(2):169-174.
24. Tolosa E., Li W., Yasuda Y., Wienhold W., Denzin L.K., Lautwein A., et al. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest 2003, 112(4):517-526.
25. Klein L., Klugmann M., Nave K.A., Tuohy V.K., Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 2000, 6(1):56-61.
26. Fan Y., Rudert W.A., Grupillo M., He J., Sisino G., Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. Embo J 2009, 28(18):2812-2824.
27. Gotter J., Brors B., Hergenhahn M., Kyewski B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 2004, 199(2):155-166.
28. Rouse R.V., Bolin L.M., Bender J.R., Kyewski B.A. Monoclonal antibodies reactive with subsets of mouse and human thymic epithelial cells. J Histochem Cytochem 1988, 36(12):1511-1517.
29. Schroter C.J., Braun M., Englert J., Beck H., Schmid H., Kalbacher H. A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J Immunol Methods 1999, 227(1-2):161-168.
30. Reich M., van Swieten P.F., Sommandas V., Kraus M., Fischer R., Weber E., et al. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins. J Leukoc Biol 2007, 81(4):990-1001.
31. Wu L., Shortman K. Heterogeneity of thymic dendritic cells. Semin Immunol 2005, 17(4):304-312.
32. Bendriss-Vermare N., Barthelemy C., Durand I., Bruand C., Dezutter-Dambuyant C., Moulian N., et al. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest 2001, 107(7):835-844.
33. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000, 165(11):6037-6046.
34. Hastings K.T., Lackman R.L., Cresswell P. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J Immunol 2006, 177(12):8569-8577.
35. Burster T., Marin-Esteban V., Boehm B.O., Dunn S., Rotzschke O., Falk K., et al. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions. Biochem Pharmacol 2007, 74(10):1514-1523.
36. Burster T., Beck A., Tolosa E., Schnorrer P., Weissert R., Reich M., et al. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J Immunol 2005, 175(9):5940-5949.
37. Stoeckle C., Sommandas V., Adamopoulou E., Belisle K., Schiekofer S., Melms A., et al. Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cell Immunol 2009, 255(1-2):41-45.
38. Oleksyszyn J., Powers J.C. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Biochemistry 1991, 30(2):485-493.
39. Lautwein A., Kraus M., Reich M., Burster T., Brandenburg J., Overkleeft H.S., et al. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J Leukoc Biol 2004, 75(5):844-855.
40. Palmer J.T., Rasnick D., Klaus J.L., Bromme D. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 1995, 38(17):3193-3196.
41. Pugliese A., Brown D., Garza D., Murchison D., Zeller M., Redondo M.J., et al. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest 2001, 107(5):555-564.
42. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435(7039):224-228.
43. Marttila J., Huttunen S., Vaarala O., Suzuki K., Elliott J.F., Narvanen A., et al. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J Autoimmun 2008, 31(2):142-148.
44. Hsing LC, EA Kirk, TS McMillen, SH Hsiao, M Caldwell, B Houston, et al, Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun. 34(2): p. 96-104.
45. Young L.J., Wilson N.S., Schnorrer P., Proietto A., Ten Broeke T., Matsuki Y., et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol 2008, 9(11):1244-1252.
46. Stoeckle C., Burster T., Gnau V., Driessen C., Kalbacher H., Melms A., et al. Is processing regulated in patients with multiple sclerosis?. Immunology 2004, 285-291.
47. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001, 2(11):1032-1039.
48. Pribyl T.M., Campagnoni C.W., Kampf K., Kashima T., Handley V.W., McMahon J., et al. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous systems. Proc Natl Acad Sci U S A 1993, 90(22):10695-10699.
49. Chignola R., Cestari T., Guerriero C., Riviera A.P., Ferrari S., Brendolan A., et al. Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies. Clin Exp Immunol 2000, 122(3):429-436.
50. Burster T., Beck A., Tolosa E., Marin-Esteban V., Rotzschke O., Falk K., et al. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. J Immunol 2004, 172(9):5495-5503.
51. Sevenich L., Hagemann S., Stoeckle C., Tolosa E., Peters C., Reinheckel T. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice. Biochimie 2010.
52. Murata S., Sasaki K., Kishimoto T., Niwa S., Hayashi H., Takahama Y., et al. Regulation of CD8 + T cell development by thymus-specific proteasomes. Science 2007, 316(5829):1349-1353.
53. Sebzda E., Wallace V.A., Mayer J., Yeung R.S., Mak T.W., Ohashi P.S. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 1994, 263(5153):1615-1618.
54. Beck H., Schwarz G., Schroter C.J., Deeg M., Baier D., Stevanovic S., et al. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol 2001, 31(12):3726-3736.
55. Costantino C.M., Hang H.C., Kent S.C., Hafler D.A., Ploegh H.L. Lysosomal cysteine and aspartic proteases are Heterogeneously expressed and Act Redundantly to initiate human invariant chain degradation. J Immunol 2008, 180(5):2876-2885.
56. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
57. Mannering S.I., Harrison L.C., Williamson N.A., Morris J.S., Thearle D.J., Jensen K.P., et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005, 202(9):1191-1197.
58. Durinovic-Bello I., Schlosser M., Riedl M., Maisel N., Rosinger S., Kalbacher H., et al. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes. Diabetologia 2004, 47(3):439-450.
59. Congia M., Patel S., Cope A.P., De Virgiliis S., Sonderstrup G. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA 1998, 95(7):3833-3838.
60. Alleva D.G., Crowe P.D., Jin L., Kwok W.W., Ling N., Gottschalk M., et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 2001, 107(2):173-180.
61. Saegusa K., Ishimaru N., Yanagi K., Arakaki R., Ogawa K., Saito I., et al. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest 2002, 110(3):361-369.
62. Fissolo N., Kraus M., Reich M., Ayturan M., Overkleeft H., Driessen C., et al. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur J Immunol 2008, 38(9):2401-2411.